BioFlyte
PrivateLast Round
Series B
Aug 10, 2023
Total Funding Raised
$12.75M
Company Overview
BioFlyte operates in Cybersecurity and is based in Albuquerque, New Mexico. Its latest recorded funding round was a Series B round in August 2023.
BioFlyte is a biodefense company that develops and commercializes fieldable aerosol mass spectrometers and biothreat surveillance solutions to protect critical infrastructure from biological and chemical threats.
Sector
Cybersecurity
Verticals
Defense Tech, Environmental Monitoring, Sensors, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioFlyte Comparables
Compare BioFlyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pilgrim Labs | 83% | |
| Zeteo Tech | 83% | |
| Chemring Group PLC | 75% |
For institutional investors. Book with your work email.
BioFlyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 10, 2023 | ||||
| Series A | Apr 19, 2022 | ||||
| Seed | Jun 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioFlyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Scout Ventures | Series B |
| New Mexico Vintage Fund | Series B |
| Cottonwood Technology Fund | Series B, Series A |
| Anzu Partners | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
Partnered with Los Alamos National Laboratory for biothreat detection modeling.
- Feb 5, 2025
US Air Force to trial dynamic threat monitoring technology.
For institutional investors. Book with your work email.
BioFlyte Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioFlyte's valuation, stock price, and market status.
Is BioFlyte a public or private company?
BioFlyte is a private company.
What is the current stock price of BioFlyte?
BioFlyte is a private company, so its shares have no public market price. Caplight tracks BioFlyte's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioFlyte worth (valuation)?
Valuation information for BioFlyte is not publicly available.
Can I buy BioFlyte stock?
BioFlyte shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioFlyte's last funding round?
BioFlyte's most recent funding round was Series B on August 10, 2023.
Who are the main investors in BioFlyte?
Key investors in BioFlyte include Scout Ventures, Cottonwood Technology Fund, Anzu Partners.
Will BioFlyte IPO soon?
No public IPO plans have been announced for BioFlyte.
How can I track BioFlyte secondary market activity?
Caplight tracks bids, offers, and trades in BioFlyte's shares on secondary markets.